|
"hsu chiun"的相关文件
显示项目 91-100 / 149 (共15页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目
| 國立臺灣大學 |
2009 |
Prognostic Factors of Survival in 236 Advanced Hepatocellular Carcinoma Patients Enrolled in Prospective Clinical Trials of Systemic Therapy
|
林宗哲; 邵幼雲; 徐志宏; 許駿; 洪瑞隆; 鄭安理; LIN, ZONG-ZHE; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; HONG, RUEY-LONG; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Strategies to Prevent Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Therapy
|
許駿; 魏淑鉁; 鄭安理; 陳培哲; HSU, CHIUN; WEI, SHU-CHEN; CHENG, ANN-LII; CHEN, PEI-JER |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Phase Ii Study of Cetuximab Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for the First-Line Treatment of Advanced Gastric Cancer
|
葉坤輝; 徐志宏; 許駿; 林璟宏; 沈盈君; 邱宗傑; 趙毅; 鄭安理; YEH, KUN-HUEI; HSU, CHIH-HUNG; HSU, CHIUN; LIN, CHING-HUNG; SHEN, YING-CHUN; CHIOU, TZEON-JYE; CHAO, YEE; CHENG, ANN-LII |
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 國立臺灣大學 |
2008 |
Serum Vascular Endothelial Growth Factor/Soluble Vascular Endothelial Growth Factor Receptor 1 Ratio Is an Independent Prognostic Marker in Pancreatic Cancer
|
Chang, Yu-Ting; Chang, Ming-Chu; Wei, Shu-Chen; Tien, Yu-Wen; Hsu, Chiun; Liang, Po-Chin; Tsao, Po-Nien; Jan, I-Shiow; Wong, Jau-Min |
| 國立臺灣大學 |
2008 |
Expression of Mitosis Regulatory Proteins in Biliary Tract Carcinoma: Correlation with Clinico-Pathological Features and Patient Outcome
|
沈盈君; 胡賦強; 鄭永銘; 張玉憲; 林宗哲; 張明志; 許駿; 鄭安理; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG -MING; CHANG, YU-SHIAHN; LIN, ZONG-ZHE; CHANG, MING-CHIH; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Comparison of Hypoplastic Myelodysplastic Syndrome (Mds) with Normo-/ Hypercellular Mds by International Prognostic Scoring System, Cytogenetic and Genetic Studies
|
黃泰中; 柯博升; 唐季祿; 許駿; 陳建源; 蔡偉; 黃聖懿; 姚明; 陳耀昌; 沈銘鏡; 王秋華; 田蕙芬; HUANG, TAI-CHUNG; KO, BO-SHENG; TANG, JIH-LUH; HSU, CHIUN; CHEN, CHIEN-YUAN; TSAY, WOEI; HUANG, SHANG-YI; YAO, MING; CHEN, YAO-CHANG; SHEN, MING- CHING; WANG, CHIU-HWA; TIEN, HWEI-FANG |
| 國立臺灣大學 |
2008 |
A Revisit of Prophylactic Lamivudine for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma: A Randomized Trial
|
許駿; 熊昭; 蘇益仁; 黃偉修; 張明志; 李啟誠; 巫宏博; 田蕙芬; 趙祖怡; 鄭安理; 陳培哲; HSU, CHIUN; HSIUNG, CHAO A.; SU, IH-JEN; HWANG, WEI-SHOU; CHANG, MING-CHIH; LI, CHI-CHENG; WU, HUNG-BO; TIEN, HWEI-FANG; CHAO, TSU-YI; CHENG, ANN -LII; CHEN, PEI-JER |
显示项目 91-100 / 149 (共15页)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每页显示[10|25|50]项目
|
